ANDA 202858, held by Invagen Pharms. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 202858 (Phentermine Hydrochloride), held by Invagen Pharms, was first approved by FDA on Feb 14, 2014, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 14, 2014 | Original application | Approved | None posted |
| Phentermine Hydrochloride15MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| Phentermine Hydrochloride30MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 1Labeling · Standard review | Approved | None posted |
| Feb 14, 2014 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters